A Study of Efficacy and Safety of TLL-018 in CSU Participants
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Chronic Spontaneous Urticaria
Related studies linked through entity extraction aliases.
To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous Urticaria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Explore the Efficacy and Safety of HWH486 in Adults With Chronic Spontaneous Urticaria
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU)
- Status
- SUSPENDED
- Phase
- NA
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE1
A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
- Status
- COMPLETED
- Phase
- N/A
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria
- Status
- UNKNOWN
- Phase
- N/A
A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases
- Status
- COMPLETED
- Phase
- PHASE1
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
- Status
- COMPLETED
- Phase
- PHASE2
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
- Status
- RECRUITING
- Phase
- PHASE4
A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.
- Status
- COMPLETED
- Phase
- PHASE3
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)
- Status
- COMPLETED
- Phase
- PHASE3